Exanthem Subitum-associated Encephalitis: Nationwide Survey in Japan
Overview
Authors
Affiliations
We sought to clarify clinical features of exanthem subitum associated-encephalitis/encephalopathy, generally caused by primary human herpesvirus-6 infection in Japan. A two-part questionnaire was sent to hospitals between January 2003-December 2004. Of 3357 questionnaires, 2357 (70.2%) were returned, and 2293 (68.3%) were eligible for analysis. Eighty-six cases of exanthem subitum-associated encephalitis/encephalopathy were reported. Seventy-seven (89.5%) of 86 patients were diagnosed with human herpesvirus-6 infection by virologic examination. Although 41 (50.6%) of 81 patients had no sequelae, 38 (46.9%) had neurologic sequelae. Moreover, two fatal cases (2.5%) were reported. Pleocytosis was evident in only 4 (7.5%) of 53 patients, and cerebrospinal fluid protein levels were within normal range (23.4 +/- 14.6 mg/dL S.D.) in all patients. Human herpesvirus-6 DNA was detected in 21 (53.8%) of 39 patients. Abnormal computed tomography findings were a predictor of neurologic sequelae (P = 0.0097). As a consequence of this survey, we estimate that 61.9 cases of exanthem subitum-associated encephalitis occur every year. The disease prognosis was unexpectedly poor.
A Rare Case of HHV-6 Encephalitis in an Immunocompetent Host: Case Report and Literature Review.
Mekheal E, Tagliaferri A, Vasquez K, Pjetergjoka R, LoBue G, Townsend D Cureus. 2022; 14(3):e23007.
PMID: 35415058 PMC: 8993705. DOI: 10.7759/cureus.23007.
Ishimaru S, Kawamura Y, Miura H, Shima S, Ueda A, Watanabe H J Neurovirol. 2021; 28(1):92-98.
PMID: 34970721 DOI: 10.1007/s13365-021-01040-5.
Hippocampal Atrophy in Pediatric Transplant Recipients with Human Herpesvirus 6B.
Miyake M, Kawamura Y, Ishihara N, Suzuki S, Miura H, Sakaguchi Y Microorganisms. 2021; 9(4).
PMID: 33917715 PMC: 8068176. DOI: 10.3390/microorganisms9040776.
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts.
Berzero G, Campanini G, Vegezzi E, Paoletti M, Pichiecchio A, Simoncelli A Neurol Neuroimmunol Neuroinflamm. 2021; 8(2).
PMID: 33587722 PMC: 7963435. DOI: 10.1212/NXI.0000000000000942.
Okutani M, Kawabata A, Nishimura M, Nagamata S, Kuwabara S, Haseda Y J Immunol Res. 2020; 2020:4697529.
PMID: 32775465 PMC: 7399772. DOI: 10.1155/2020/4697529.